Drug Propsecting In Africa ASA 2006 Online


Published on

Talk presented at the 2006 African Studies Association Meeting in San Francisco, CA by Abena Dove Osseo-Asare, Assistant Professor, Department of History, University of California, Berkeley

Published in: Education, Technology
  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide
  • What exactly is indigenous knowledge and is bioprospecting the way to preserve it? Problem of it being embodied in certain classes of individuals. To illustrate my point, some images from Popular literature in the US 1993 Art Davidson: Endangered Peoples– person superimposed on the tropical terrain Asante healer-priest From African Ceremonies by photographer Carol Beckwith & Angela fisher– this is indeed a healer chanelling spirits, use of white powder, but something for festivals, not exactly in line with Nana Drobo off in Japan Chris kilham- “medicine hunter” looking for Kava in the south pacific 1996– been to ghana, one healer I met had his business card and asked me if I knew him, because he had taken some plants not heard back. Interested in this guy– the intermediary
  • Drug Propsecting In Africa ASA 2006 Online

    1. 1. Drug Prospecting in Africa : Historical Lessons from Madagascar Periwinkle to Ghana Quinine Abena Dove Osseo-Asare, PhD Department of History University of California, Berkeley [email_address]
    2. 2. ‘Bioprospecting’ <ul><li>8(j) [Each Contracting Party shall, as far as possible and as appropriate:] Subject to its national legislation, respect, preserve and maintain knowledge, innovations and practices of indigenous and local communities embodying traditional lifestyles relevant for the conservation and sustainable use of biological diversity and promote their wider application with the approval and involvement of the holders of such knowledge, innovations and practices and encourage the equitable sharing of the benefits arising from the utilization of such knowledge, innovations and practices; </li></ul><ul><ul><ul><li>-Convention on Biological Diversity, Rio de Janeiro 1993 </li></ul></ul></ul>
    3. 3. Case 1: Madagascar Periwinkle &quot;In this case I do not believe there is a compelling reason to suggest that Madagascar’s role in the discovery of the pharmacological action of a few of the alkaloids from this plant represents “easy picking” or any logical requirement for compensation. It was certainly not easy and required millions of dollars of investment. Should Jamaica, the Philippine Islands, Texas, Florida, and so forth also have shared? The share would have been infinitesimal and illogical. Should China continue to receive payments for digitalis and the United Kingdom for penicillin?&quot; – Irving Johnson, Eli Lilly (1992)
    4. 4. Case 2: Ghana Quinine N N CH 3 Cryptotackieine (1996) Cryptolepis sanguinolenta
    5. 5. Albert Nii Tackie State-sponsored Herbal Research dating to 1950s
    6. 6. Oku Ampofo
    7. 8. Benefit-Sharing in Africa <ul><li>Historical Dynamics of Bioprospecting important to understand traditional knowledge and intellectual property debates </li></ul><ul><li>Are genetic rights claims feasible for states given geographic distribution of plants? </li></ul><ul><li>Are traditional knowledge claims for specific ethnic groups feasible or advisable in Africa? </li></ul><ul><li>Enduring historical significance of patent claims to both African and Expatriate researchers. </li></ul>
    8. 9. Talk presented at the 2006 meeting of the African Studies Association Meeting in San Francisco, CA by Abena Dove Osseo-Asare email: [email_address] http://osseo.berkeley.edu